Effects of Rifaximin on Bacterial Translocation in Thioacetamide-Induced Liver Injury in Rats

[1]  Claudia Cesaro,et al.  Rifaximin in the treatment of hepatic encephalopathy , 2011, Hepatic medicine : evidence and research.

[2]  R. Sun,et al.  Toll-like receptors in acute liver injury and regeneration. , 2011, International immunopharmacology.

[3]  H. Dupont,et al.  Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases , 2010, Current opinion in gastroenterology.

[4]  A. Gasbarrini,et al.  Rifaximin pharmacology and clinical implications , 2009, Expert opinion on drug metabolism & toxicology.

[5]  S. Raptis,et al.  Intestinal decontamination improves liver haemodynamics in patients with alcohol‐related decompensated cirrhosis , 2009, Alimentary pharmacology & therapeutics.

[6]  A. Marchese,et al.  Effects of Rifaximin on Bacterial Virulence Mechanisms at Supra- and Sub-Inhibitory Concentrations , 2008, Journal of chemotherapy.

[7]  B. Zilberstein,et al.  Bacterial translocation: Overview of mechanisms and clinical impact , 2007, Journal of gastroenterology and hepatology.

[8]  N. Karadaǧ,et al.  The effects of Gingko biloba, vitamin E and melatonin on bacterial translocation in thioacetamide-induced fulminant hepatic failure in rats. , 2006, Acta gastro-enterologica Belgica.

[9]  S. Sakaguchi,et al.  Oxidative stress and septic shock: metabolic aspects of oxygen-derived free radicals generated in the liver during endotoxemia. , 2006, FEMS immunology and medical microbiology.

[10]  María Inés Torres,et al.  Hepatotoxic Agent Thioacetamide Induces Biochemical and Histological Alterations in Rat Small Intestine , 1997, Digestive Diseases and Sciences.

[11]  N. Weizman,et al.  Melatonin inhibits nuclear factor kappa B activation and oxidative stress and protects against thioacetamide induced liver damage in rats. , 2004, Journal of hepatology.

[12]  A. Morelli,et al.  Inhibition of Intestinal Bacterial Translocation with Rifaximin Modulates Lamina propria Monocytic Cells Reactivity and Protects against Inflammation in a Rodent Model of Colitis , 2003, Digestion.

[13]  Dewu Han.  Intestinal endotoxemia as a pathogenetic mechanism in liver failure. , 2002, World journal of gastroenterology.

[14]  F. Allerberger,et al.  Effects of daily oral administration of rifaximin and neomycin on faecal aerobic flora in rats. , 2001, Pharmacological research.

[15]  E. Cabré,et al.  Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis , 2000, Hepatology.

[16]  C. Guarner,et al.  Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. , 1997, Journal of hepatology.

[17]  B. Jeppsson,et al.  Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat , 1997, Hepatology.

[18]  C. C. Wu,et al.  Bacterial translocation in the course of acute pancreatitis: beneficial role of nonabsorbable antibiotics and lactitol enemas. , 1996, Digestion.

[19]  J. Llovet,et al.  Selective intestinal decontamination with norfloxacin reduces bacterial translocation in ascitic cirrhotic rats exposed to hemorrhagic shock , 1996, Hepatology.

[20]  R. N. Brogden,et al.  A Review of its Antibacterial Activity , Pharmacokinetic Properties and Therapeutic Potential in Conditions Mediated by Gastrointestinal Bacteria , 2012 .

[21]  D. Wilmore,et al.  Hepatic failure and coma after liver resection is reversed by manipulation of gut contents: the role of endotoxin. , 1991, Surgery.

[22]  W A Buurman,et al.  Suppression of cellular immunity in obstructive jaundice is caused by endotoxins: a study with germ-free rats. , 1990, Gastroenterology.

[23]  P. L. Searle.  The berthelot or indophenol reaction and its use in the analytical chemistry of nitrogen. A review , 1984 .

[24]  L. Zieve.  Amino acids in liver failure. , 1979, Gastroenterology.